Seda Duman Öztürk

9PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesCommunication technology and digital media studiesCancer therapy (excl. chemotherapy and radiation therapy)Allergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 16, 2026
Sortilin Immunoreactivity Is Associated with Lymphatic and Extrathyroidal Invasion in Medullary Thyroid Carcinoma: A Preliminary Single-Center Study.

|Sep 09, 2026
Association of ADAM17 expression with CD4 + and CD8 + tumor-infiltrating lymphocytes in adrenocortical carcinoma and benign adrenal adenoma.

|May 06, 2026
Social media use and perceptions among pathologists in Turkey: a national survey.

|Sep 09, 2024
Reporting Hormone Receptor Expression in Breast Carcinomas: Which Method has the Highest Prognostic Power and What Should be the Optimal Cut-off Value?

Çiğdem Öztürk, Oğuzhan Okcu, Seda Duman Öztürk

|Mar 28, 2023
Does Apoptotic Index Predict the Response to Neoadjuvant Chemotherapy in Patients with Breast Carcinoma?

Gokce Askan, Oguzhan Okcu, Cigdem Ozturk

|Mar 15, 2023
Predicting response to neoadjuvant therapy with glucose transporter-1 in breast cancer.

Seda Duman Öztürk, Çiğdem Öztürk, Oğuzhan Okcu

Pageof 2

Frequent Collaborators

5 joint publications

Çiğdem Öztürk

4 joint publications

Oğuzhan Okcu

4 joint publications

Gökçe Aşkan

3 joint publications

Bayram Sen